InsidersTradesSigma
Explore the full record of transactions filed by Shmerling James E., Director. Insider active across 1 companies, notably Biostage, Inc.. Aggregated, 1 filings have been published. Total volume traded: €96k. The latest transaction was disclosed on 12 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
James E. Shmerling serves as a Board Member at Biostage, Inc. With significant experience in the industry, he contributes to the governance of the company and strategic decision-making. His role as a board member involves overseeing operations and ensuring compliance with applicable regulations. James E. Shmerling is committed to promoting shareholder interests and supporting Biostage, Inc.'s mission in the biotechnology field.